Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.
Treatment with a high-dose, intravenous bolus of methylprednisolone has been reported in numerous cases of rheumatic diseases. The optimal routes of administration, dosage, dosage interval, and other factors are unknown. This report describes uncontrolled clinical observations with a single dose of...
Kaydedildi:
| Yayımlandı: | Ann Rheum Dis |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
1983
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001138/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6602594/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.42.3.308 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|